Therapeutic Area | MeSH |
---|---|
signs and symptoms pathological conditions | D013568 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
OXYCODONE HYDROCHLORIDE | Genus Lifesciences | N-200534 RX | 2010-10-20 | 1 products, RLD, RS |
OXYCODONE HYDROCHLORIDE | Genus Lifesciences | N-200535 RX | 2010-10-20 | 2 products, RLD, RS |
ROXYBOND | Protega Pharmaceuticals | N-209777 RX | 2017-04-20 | 4 products |
OXYCONTIN | Purdue Pharma | N-022272 RX | 2010-04-05 | 7 products, RLD |
ROXICODONE | SPECGX | N-021011 RX | 2000-08-31 | 3 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
TARGINIQ | Purdue Pharma | N-205777 DISCN | 2014-07-23 | 3 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
XARTEMIS XR | Mallinckrodt | N-204031 DISCN | 2014-03-11 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
COMBUNOX | Forest Laboratories | N-021378 DISCN | 2004-11-26 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
XTAMPZA ER | Collegium Pharmaceutical | N-208090 RX | 2016-04-26 | 5 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
endocet | ANDA | 2024-08-27 |
endodan | NDA authorized generic | 2011-05-23 |
nalocet | ANDA | 2024-08-06 |
oxaydo | New Drug Application | 2024-04-24 |
oxycodone | ANDA | 2022-09-22 |
oxycodone and acetaminophen | ANDA | 2024-09-16 |
oxycodone and acetaminophen oxycodone hydrochloride | ANDA | 2023-10-24 |
oxycodone and aspirin | ANDA | 2023-09-18 |
oxycodone hcl | NDA authorized generic | 2021-10-30 |
oxycodone hcl controlled-release | New Drug Application | 2010-01-14 |
Expiration | Code | ||
---|---|---|---|
OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, GENUS LIFESCIENCES | |||
2024-07-21 | M-14 | ||
OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, VISTAPHARM | |||
2024-07-21 | M-14 |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Oxycodone, Xtampza Er, Collegium Pharm Inc | |||
9737530 | 2036-09-02 | DP | U-1556 |
9968598 | 2036-09-02 | DP | U-1556 |
10188644 | 2036-09-02 | DP | U-1556 |
10646485 | 2036-09-02 | DP | U-1556 |
9682075 | 2030-12-10 | DP | U-1556 |
10004729 | 2030-12-10 | DP | U-1556 |
10668060 | 2030-12-10 | DP | U-1556 |
8758813 | 2025-06-10 | U-1556 | |
7399488 | 2025-03-24 | DP | |
7771707 | 2025-03-24 | DP | |
8449909 | 2025-03-24 | DP | |
8557291 | 2025-03-21 | DP | |
Acetaminophen / Oxycodone Hydrochloride, Xartemis Xr, Mallinckrodt Inc | |||
8658631 | 2032-05-16 | DP | |
8741885 | 2032-05-16 | DP | U-1499 |
8992975 | 2032-05-16 | DP | |
9050335 | 2032-05-16 | DP | |
9468636 | 2032-05-16 | U-1499 | |
8597681 | 2030-12-21 | DP | |
8980319 | 2030-12-21 | DP | |
8377453 | 2029-11-19 | DP | U-1499 |
8372432 | 2029-03-11 | DP | U-1499 |
8394408 | 2029-03-11 | DP | |
8668929 | 2029-03-11 | U-1499 | |
7976870 | 2027-06-01 | U-1498 | |
Oxycodone Hydrochloride, Oxycontin, Purdue Pharma Lp | |||
8894987 | 2030-03-29 | DP | |
8808741 | 2027-08-24 | U-1556 | |
8894988 | 2027-08-24 | DP | |
9492389 | 2027-08-24 | DP | |
9492391 | 2027-08-24 | U-1556 | |
9492392 | 2027-08-24 | DP | |
9492393 | 2027-08-24 | U-1556 | |
9763933 | 2027-08-24 | DP | |
9770416 | 2027-08-24 | DP | |
9775808 | 2027-08-24 | DP | |
11304908 | 2027-08-24 | DP | |
11304909 | 2027-08-24 | U-1556 | |
10407434 | 2025-03-30 | DP | |
10696684 | 2025-03-30 | DP | |
Oxycodone Hydrochloride, Roxybond, Protega Pharms | |||
7955619 | 2028-08-12 | DP | |
10314788 | 2028-08-12 | DP | |
Naltrexone Hydrochloride / Oxycodone Hydrochloride, Troxyca Er, Pfizer | |||
7815934 | 2027-12-12 | DP | |
8685443 | 2025-07-03 | U-1508 | |
Naloxone Hydrochloride / Oxycodone Hydrochloride, Targiniq, Purdue Pharma Lp | |||
9073933 | 2025-03-30 | DP | |
9522919 | 2025-03-30 | DS, DP | |
Oxycodone Hydrochloride, Oxaydo, Zyla | |||
7201920 | 2025-03-16 | DP | |
9492443 | 2024-05-26 | DP |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Postoperative pain | D010149 | — | G89.18 | 7 | 8 | 34 | 68 | 58 | 175 |
Pain | D010146 | EFO_0003843 | R52 | 14 | 20 | 38 | 27 | 29 | 127 |
Healthy volunteers/patients | — | — | — | 44 | 1 | — | 2 | 1 | 47 |
Opioid-related disorders | D009293 | EFO_0005611 | F11 | 12 | 14 | — | 8 | 10 | 42 |
Chronic pain | D059350 | HP_0012532 | — | 6 | 6 | 10 | 13 | 6 | 41 |
Back pain | D001416 | HP_0003418 | M54 | 1 | 2 | 22 | 7 | 4 | 36 |
Low back pain | D017116 | HP_0003419 | M54.5 | 1 | 2 | 19 | 7 | 5 | 34 |
Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | 1 | 7 | 14 | 9 | 3 | 34 |
Acute pain | D059787 | — | R52 | 5 | 7 | 7 | 4 | 10 | 33 |
Cancer pain | D000072716 | — | G89.3 | — | 6 | 7 | 9 | 5 | 27 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Anesthesia | D000758 | — | — | — | 1 | 1 | — | 7 | 8 |
Hip osteoarthritis | D015207 | EFO_1000786 | M16 | — | — | 2 | — | 5 | 7 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | 1 | — | 2 | — | 1 | 4 |
Replacement arthroplasty knee | D019645 | — | — | 1 | — | 1 | — | 2 | 4 |
Arthralgia | D018771 | HP_0002829 | M25.5 | — | 1 | 3 | — | — | 4 |
Joint diseases | D007592 | HP_0003040 | M12.9 | — | — | 2 | — | 1 | 3 |
Mucositis | D052016 | EFO_1001898 | — | 1 | — | 1 | — | 1 | 3 |
Arthroplasty | D001178 | — | — | — | — | 1 | — | 1 | 2 |
Obesity | D009765 | EFO_0001073 | E66.9 | — | — | 1 | — | 1 | 2 |
Brachial plexus block | D065527 | — | — | — | — | 1 | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Emergencies | D004630 | — | — | — | 1 | — | — | 5 | 6 |
Lung neoplasms | D008175 | HP_0100526 | C34.90 | 1 | 2 | — | — | 1 | 4 |
Syndrome | D013577 | — | — | — | 1 | — | — | 2 | 3 |
Anesthesia and analgesia | D000760 | — | — | 2 | 2 | — | — | 1 | 3 |
Adenoidectomy | D000233 | — | — | 2 | 2 | — | — | — | 2 |
Leiomyoma | D007889 | HP_0000131 | D25 | — | 1 | — | — | 1 | 2 |
Myofibroma | D047708 | — | — | — | 1 | — | — | 1 | 2 |
Nasopharyngeal carcinoma | D000077274 | — | — | — | 1 | — | — | 1 | 2 |
Dental pins | D003772 | — | — | — | 1 | — | — | — | 1 |
Heroin dependence | D006556 | EFO_0004240 | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Obstetric labor complications | D007744 | — | — | 1 | — | — | — | 3 | 4 |
Drug interactions | D004347 | — | — | 1 | — | — | — | 2 | 3 |
Hypercapnia | D006935 | — | — | 3 | — | — | — | — | 3 |
Stomatitis | D013280 | EFO_1001904 | K12.1 | 2 | — | — | — | 1 | 3 |
Cesarean section | D002585 | — | — | 1 | — | — | — | 1 | 2 |
Colorectal neoplasms | D015179 | — | — | 1 | — | — | — | 1 | 2 |
Impacted tooth | D014095 | HP_0011079 | K01.1 | 1 | — | — | — | 1 | 2 |
Squamous cell carcinoma of head and neck | D000077195 | — | — | 1 | — | — | — | 1 | 2 |
Anxiety disorders | D001008 | EFO_0006788 | F41.1 | 1 | — | — | — | 1 | 2 |
Recreational drug use | D000084783 | — | — | 2 | — | — | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Conduction anesthesia | D000765 | — | — | — | — | — | — | 4 | 4 |
Heart failure | D006333 | HP_0001635 | I50 | — | — | — | — | 3 | 3 |
Aortic dissection | D000784 | — | I71.0 | — | — | — | — | 3 | 3 |
Thoracic surgical procedures | D019616 | — | — | — | — | — | — | 3 | 3 |
Laparoscopy | D010535 | — | — | — | — | — | — | 3 | 3 |
Hypertension | D006973 | EFO_0000537 | I10 | — | — | — | — | 2 | 2 |
Infections | D007239 | EFO_0000544 | — | — | — | — | — | 2 | 2 |
Menorrhagia | D008595 | EFO_0003945 | N92.0 | — | — | — | — | 2 | 2 |
Hemophilia a | D006467 | EFO_0007267 | D66 | — | — | — | — | 2 | 2 |
Pneumonia | D011014 | EFO_0003106 | — | — | — | — | — | 2 | 2 |
Drug common name | Oxycodone |
INN | oxycodone |
Description | Oxycodone is a semisynthetic opioid of formula C18H21NO4 that is derived from thebaine. It is a moderately potent opioid analgesic, generally used for relief of moderate to severe pain. It has a role as an opioid analgesic, a mu-opioid receptor agonist and an antitussive. It is an organic heteropentacyclic compound and a semisynthetic derivative. It is functionally related to a thebaine. It is a conjugate base of an oxycodone(1+). It derives from a hydride of a morphinan. |
Classification | Small molecule |
Drug class | Opioid |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314 |
PDB | — |
CAS-ID | 76-42-6 |
RxCUI | — |
ChEMBL ID | CHEMBL656 |
ChEBI ID | 7852 |
PubChem CID | 5284603 |
DrugBank | DB00497 |
UNII ID | CD35PMG570 (ChemIDplus, GSRS) |